Product Information
FENOFIBRATE 67 MG CAPSULE is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.0898 per EA under NDC 68462058001. Its NADAC has been published 484 times since May 17, 2017.
FDA first approved this application on Apr 7, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
67 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462058001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA205566FDA Approved
4/7/2017
TE Code
AB
On Market Since
4/7/2017
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 67 MG CAPSULE has been published 484 times since May 17, 2017, and over the history we have for it it has declined 85.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0898 per EA |
|---|---|
| All-time high | $0.6545 (Jul 12, 2017) |
| All-time low | $0.0646 (Jun 19, 2024) |
| 52-week high | $0.0931 |
| 52-week low | $0.0783 |
| Median price | $0.1396 |
| Average price | $0.2281 |
| Largest weekly change | +67.0% (Mar 23, 2022) |
| Weeks tracked | 484 |
| Tracking since | May 17, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FENOFIBRATE 67 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 67 MG CAPSULE, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.0898 per EA (NDC 68462058001), effective Aug 19, 2026.
How has the price of FENOFIBRATE 67 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 67 MG CAPSULE has declined 85.5%. It has been tracked across 484 weekly CMS publications since May 17, 2017.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 67 MG CAPSULE?
Since May 17, 2017, the NADAC for FENOFIBRATE 67 MG CAPSULE has ranged from a low of $0.0646 (Jun 19, 2024) to a high of $0.6545 (Jul 12, 2017), with a median of $0.1396 per EA.
Are there cheaper alternatives to FENOFIBRATE 67 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FENOFIBRATE 67 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures FENOFIBRATE 67 MG CAPSULE?
FENOFIBRATE 67 MG CAPSULE (NDC 68462058001) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.